0001575872-22-001063.txt : 20221102 0001575872-22-001063.hdr.sgml : 20221102 20221102062242 ACCESSION NUMBER: 0001575872-22-001063 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20221101 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DR REDDYS LABORATORIES LTD CENTRAL INDEX KEY: 0001135951 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15182 FILM NUMBER: 221352199 BUSINESS ADDRESS: STREET 1: 8-2-337, ROAD NO.3 BANJARA HILLS CITY: HYDERABAD STATE: K7 ZIP: 500-034 BUSINESS PHONE: 91 40 49002900 MAIL ADDRESS: STREET 1: 8-2-337, ROAD NO.3 BANJARA HILLS CITY: HYDERABAD STATE: K7 ZIP: 500-034 6-K 1 drr0439_6k.htm FORM 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

November, 2022

 

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x                                  Form 40-F   ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨                                  No x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

 

 

   

 

 

EXHIBITS

 

Exhibit
Number

  Description of Exhibits
   
99.1   Intimation dated November 1, 2022 regarding participation at investor conferences

 

   

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

DR. REDDY’S LABORATORIES LIMITED

(Registrant)

         
Date: November 1, 2022 By: /s/ K Randhir Singh  
    Name: K Randhir Singh  
    Title: Company Secretary  

 

   

 

 

 

EX-99.1 2 drr0439_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

November 1, 2022

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

 

Dear Sirs,

 

Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

 

This is to inform you that the Company’s management will be participating in the following investor conferences for group and one-on-one meetings:

 

Date   Conference   Location
November 2, 2022   Nomura Virtual India Corporate Day Nov 2022   Virtual
November 9, 2022   UBS India Virtual Conference 2022   Virtual
November 14, 2022   25th Annual CITICS CLSA India Forum 2022   Mumbai
November 17, 2022   Centrum–Orion 2022 II – “One India- Many Paths to Prosperity”   Virtual

 

Please note that the schedule of the aforesaid meetings is subject to change due to any exigencies on the part of investors / Company.

 

This is for your information.

 

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

/s/ K Randhir Singh    
K Randhir Singh    

Company Secretary & Compliance Officer

 

CC:- New York Stock Exchange Inc.(Stock Code :RDY)
  NSE IFSC Ltd

 

   

 

 

 

GRAPHIC 3 drr0439_ex99-1img01.jpg GRAPHIC begin 644 drr0439_ex99-1img01.jpg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end